Research Strategy

main content

Strong academic disciplines are essential for robust research. However, global challenges do not neatly coincide with academic subjects, so the boundaries between subjects must be flexible in order to solve major concerns such as: climate change; sustainable energy; lifelong healthcare; the relief of poverty, thirst and hunger; social cohesion and understanding; and the improvement of education.

Multidisciplined approach
We recognise that the way we are organised and function must be adaptable, allowing our staff to identify significant challenges and prepare to meet them. In the same way, our researchers are supported to develop academic and practical strengths, but we also encourage them to look beyond the traditional limits of their subject and create multidisciplined solutions which will have significant impact in the world we live today. See how we initiate new, long-term collaborations between disciplines and find out about some of our multidisciplinary work in Research Approach.

Collaborative work
We are highly successful at working in collaboration with business and industry, the public sector and wider civic society to generate mutual benefit. Among our partners are organisations with global presence, though we also acknowledge fully the role that small to medium-sized enterprises have in the creation of new knowledge and technologies. See some examples of our research collaborations in the right-hand column. If you would like to find out how your organisation can collaborate with our researchers, please visit our Business & Organisations webpages.

Investment in facilities
We are committed to a £350m investment over the next 10 years to transform our campus. Our commitment to cutting-edge research is demonstated by significant investment in world-class infrastructure, including:  

The new Technology and Innovation Centre (TIC) symbolises our commitment to collaboration and multidisciplinary research. At 22 thousand square metres and with an investment of over £100m, TIC is our most ambitious campus development for research, education and knowledge exchange across all four Faculties with a primary focus on energy, enabling technologies and pharmaceutical manufacturing. TIC is a partnership between the University, Scottish Government, Scottish Enterprise and global companies from these key industrial sectors. The building will be completed in 2014.

The Strathclyde Institute of Pharmacy & Biomedical Science (SIPBS) is a recent £36m biomedical building for healthcare research in drug discovery and development. SIPBS is redefining multidisciplinary approaches to life sciences research and knowledge exchange in partnership with organisations such as the NHS, CRUK and international pharmaceutical companies. Research is also advanced through six research groups: Cardiovascular; Cell Biology; Infection, Immunity & Microbiology; Medicines Use & Health; Neuroscience; and Pharmaceutical Sciences.

The Advanced Forming Research Centre (AFRC) provides industrial-scale forming research capability and programmes in an environment ranging from microscopy to large-scale industrial presses. The AFRC is a £30m venture between the Department of Design, Manufacture & Engineering Management, the Department of Mechanical Engineering and global companies including Rolls–Royce, Boeing, Mettis Aerospace, Timet and Aubert & Duval.

Research pooling
We are committed to the pooling of research strategies, expertise and resources across Scotland. Prompted by the Scottish Funding Council, these unique collaborative initiatives ensure that Scottish research remains competitive, sustainable and of an internationally-leading standard. We are a partner of the following research pools:

Search our expertise

Search for our specialists, published research, research impact, projects and activities.

Bridging the Gap (BTG) is an initiative at Strathclyde to stimulate research across the boundaries of traditional disciplines with the aim of addressing global challenges.

Find out how your organisation can benefit from our research expertise, research facilities and technological innovations.

Case studies

Find out how we developed a highly successful continuous development programme for GSK.

Read about the development of a powerful new antibiotic treatment for deadly infections which has been licensed by MGB Biopharma.

Read about one of Strathclyde's successful spin-out companies that licensed our revolutionary tidal turbine technology.

Read about some of our recent research projects supported by the Engineering and Physical Sciences Research Council (EPSRC) Pathways to Impact programme.

Learn how our KTP projects with Scottoiler helped to transform the company into a multi-product, global business.

Read about some of Strathclyde Business School's recent research.

Read about our collaborative research and development projects with the Weir Group.